SCHEMBL11179366

SCHEMBL11179366

ClCCCCSCc1cccnc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.42
CYP2A6 P11509 1/20 0.42
CYP1A2 P05177 4/20 0.42
CYP2D6 P10635 3/20 0.42
CYP3A4 P08684 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CHRNA7 P36544 1/20 0.41
HRH1 P35367 2/20 0.40
DAO P14920 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
HTT P42858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CHRNB2 P17787 2/20 0.40
CHRNA4 P43681 2/20 0.40
HRH4 Q9H3N8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11177988 0.95 CHRM2 (0.47) CHRM2CYP2A6CYP1A2CYP2D6CYP3A4
SCHEMBL22922294 0.84 CHRM2 (0.46) CHRM2CYP2A6CYP1A2CYP2D6CYP3A4
SCHEMBL30732355 0.82 CYP1A2 (0.50) CYP2A6CYP1A2CYP2D6CYP3A4TDP1
SCHEMBL29152282 0.82 CYP1A2 (0.50) CYP2A6CYP1A2CYP2D6CYP3A4TDP1
SCHEMBL7545506 0.81 CYP2A6 (0.61) CHRM2CYP2A6CYP1A2CYP2D6CYP3A4
SCHEMBL9696232 0.80 CYP1A2 (0.48) CYP2A6CYP1A2CYP2D6CYP3A4TDP1
SCHEMBL7405579 0.80 CYP1A2 (0.56) CYP2A6CYP1A2CYP2D6TDP1L3MBTL1
SCHEMBL7391468 0.78 CYP2C19 (0.50) CYP1A2CYP2D6CYP3A4CYP2C9CYP2C19
SCHEMBL28479002 0.78 L3MBTL1 (0.42) CHRM2CYP2A6CYP1A2CYP2D6CYP3A4
SCHEMBL9865840 0.77 CHRNA7 (0.58) CYP2A6CYP1A2CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4379154-A Thiocarboxamide derivatives and their use as pharmaceuticals RHONE-POULENC SANTE (FR) 1983-04-05 US disclosed